Drug stocks are sliding on fears of Zantac lawsuits — here's what it means for JNJ

Here's our estimate of what Johnson & Johnson's potential exposure to this litigation could be in a worst-case scenario.

from US Top News and Analysis https://ift.tt/lO7icAh
https://ift.tt/rUDx1Gg